Lifestyle modification in the pharmacologic treatment of obesity: A pilot investigation of a potential primary care approach

Obesity Research

Volumn 5, Issue 3, 1997, Pages 218-226

  Wadden, Thomas A ^a,b   Berkowitz, Robert I ^a   Vogt, Renee A ^a   Steen, Suzanne N ^a   Stunkard, Albert J ^a   Foster, Gary D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Anorectic medications; Behavior modification; Fenfluramine; Obesity; Pharmacotherapy; Phentermine

Indexed keywords

ANOREXIGENIC AGENT; FENFLURAMINE; LIPID; PHENTERMINE;

ADULT; AFFECT; ARTICLE; BEHAVIOR THERAPY; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEEDING BEHAVIOR; FEMALE; GROUP THERAPY; HUMAN; LIFESTYLE; OBESITY; PATIENT COMPLIANCE; PHYSICIAN ATTITUDE; PILOT STUDY; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; TIME; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; AFFECT; APPETITE DEPRESSANTS; BEHAVIOR THERAPY; FEEDING BEHAVIOR; FEMALE; FENFLURAMINE; HUMANS; LIFE STYLE; LIPIDS; OBESITY; PATIENT COMPLIANCE; PHENTERMINE; PHYSICIAN'S ROLE; PILOT PROJECTS; PSYCHOTHERAPY, GROUP; TIME FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 0031136587     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1550-8528.1997.tb00296.x     Document Type: Article

References (10)

1. Abenhaim L, Moride Y, Brenot F, et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med. 1996;335:609-616.
2. Andersen RE, Wadden TA, Bartlett SJ, Vogt RA, Weinstock R. Weight loss and changes in serum lipids and lipoproteins in obese women. Am J Clin Nutr. 1995;62:350-357.
3. Astrup A, Toubro S, Cannon S, Hein P, Madsen J. Thermogenic synergism between ephedrine and caffeine in healthy volunteers: A double-blind, placebo controlled study. Metabolism. 1991;40:323-329.
4. Atkinson RL, Blank RC, Loper JF, Schumacher D, Lutes RA. Combined drug treatment of obesity. Obes Res. 1995;3:497S-500S.
5. Beck AT, Steer R. Manual for the Beck Depression Inventory. New York: Psychological Corp, 1987.
6. Blackburn GL. Effect of degree of weight loss on health benefits. Obes Res. 1995;3:211S-216S.
7. Blundell JE, Lawton CL. Pharmacological aspects of appetite regulation. In: Stunkard AJ, Wadden TA, eds. Obesity: Theory and Therapy. New York: Raven Press; 1993;63-76.
8. Bray GA. Use and abuse of appetite-suppressant drugs in the treatment of obesity. Ann Intern Med. 1993;119:707-713.
9. Bray GA, Ryan DH, Gordon D, Heidingsfelder S, Cerise F, Wilson K. A double-blind randomized placebo controlled trial of sibutramine. Obes Res. 1996;4:263-270.
10. Brownell KD. The LEARN Program for Weight Control (6th edition). Dallas: American Health Publishing; 1994.